Article
CRISPR/Cas9 engineering of albino cystinuria Type A mice.
Genesis (New York, N.Y. : 2000) - 1 May 2020
Beckermann Thomas M, Welch Richard C, Williams Felisha M, Mortlock Douglas P, Sha Feng, Ikizler Talat A, Woodard Lauren E, Wilson Matthew H
Abstract excerpt
Cystinuria Type A is a relatively common genetic kidney disease occurring in 1 in 7,000 people worldwide that results from mutation of the cystine transporter rBAT encoded by Slc3a1. We used CRISPR/Cas9 technology to engineer cystinuria Type A mice via genome editing of the C57BL/6NHsd background. These mice are an improvement on currently available models as they are on a coisogenic genetic background and have a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
